Mechanism of Polymerase II Transcription Repression by the Histone Variant macroH2A

Institut Albert Bonniot, INSERM U309, 38706 La Tronche cedex, France.
Molecular and Cellular Biology (Impact Factor: 4.78). 03/2006; 26(3):1156-64. DOI: 10.1128/MCB.26.3.1156-1164.2006
Source: PubMed


macroH2A (mH2A) is an unusual histone variant consisting of a histone H2A-like domain fused to a large nonhistone region.
In this work, we show that histone mH2A represses p300- and Gal4-VP16-dependent polymerase II transcription, and we have dissected
the mechanism by which this repression is realized. The repressive effect of mH2A is observed at the level of initiation but
not at elongation of transcription, and mH2A interferes with p300-dependent histone acetylation. The nonhistone region of
mH2A is responsible for both the repression of initiation of transcription and the inhibition of histone acetylation. In addition,
the presence of this domain of mH2A within the nucleosome is able to block nucleosome remodeling and sliding of the histone
octamer to neighboring DNA segments by the remodelers SWI/SNF and ACF. These data unambiguously identify mH2A as a strong
transcriptional repressor and show that the repressive effect of mH2A is realized on at least two different transcription
activation chromatin-dependent pathways: histone acetylation and nucleosome remodeling.

Download full-text


Available from: Dimitar Angelov, Oct 04, 2015
28 Reads
  • Source
    • "The name mH2A is derived from the structural feature of this histone variant, which contains a large nonhistone region (NHR), known as the macro domain, on its N-terminus.41 As a consequence, the NHR of mH2A alters nucleosome structure and interferes with the transcription machinery.42 "
    [Show abstract] [Hide abstract]
    ABSTRACT: In recent years, facilitated by rapid technological advances, we are becoming more adept at probing the molecular processes, which take place in the nucleus, that are crucial for the hierarchical regulation and organization of chromatin architecture. With an unprecedented level of resolution, a detailed atlas of chromosomal structures (histone displacement, variants, modifications, chromosome territories, and DNA looping) and mechanisms underlying their establishment, provides invaluable insight into physiological as well as pathological phenomena. In this review, we will focus on prostate cancer, a prevalent malignancy in men worldwide, and for which a curative treatment strategy is yet to be attained. We aim to catalog the most frequently observed oncogenic alterations associated with chromatin conformation, while emphasizing the TMPRSS2-ERG fusion, which is found in more than one-half of prostate cancer patients and its functions in compromising the chromatin landscape in prostate cancer.
    The Application of Clinical Genetics 05/2014; 7:81-91. DOI:10.2147/TACG.S35598
  • Source
    • "The repressive mode of action for the macrohistones has been attributed to the interference with p300-dependent histone acetylation and the hindrance of transcription factor NF-κβ binding, as well as the inhibition of nucleosome remodeling and repositioning by SWI/SNF and ACF [18], [19]. The later finding has recently been challenged by data showing that mH2A1-containing nucleosomes were efficiently mobilized by both complexes, although mH2A1 specifically reduced SWI/SNF recruitment to a DNA template containing a nucleosome positioning sequence [20]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Macrohistones (mH2As) are unusual histone variants found exclusively in vertebrate chromatin. In mice, the H2afy gene encodes two splice variants, mH2A1.1 and mH2A1.2 and a second gene, H2afy2, encodes an additional mH2A2 protein. Both mH2A isoforms have been found enriched on the inactive X chromosome (Xi) in differentiated mammalian female cells, and are incorporated into the chromatin of developmentally-regulated genes. To investigate the functional significance of mH2A isoforms for X chromosome inactivation (XCI), we produced male and female embryonic stem cell (ESC) lines with stably-integrated shRNA constructs that simultaneously target both mH2A1 and mH2A2. Surprisingly, we find that female ESCs deficient for both mH2A1 and mH2A2 readily execute and maintain XCI upon differentiation. Furthermore, male and female mH2A-deficient ESCs proliferate normally under pluripotency culture conditions, and respond to several standard differentiation procedures efficiently. Our results show that XCI can readily proceed with substantially reduced total mH2A content.
    PLoS ONE 06/2011; 6(6):e21512. DOI:10.1371/journal.pone.0021512 · 3.23 Impact Factor
  • Source
    • "The chromatin-remodelling complex SWI/SNF is unable to remodel in the presence of macroH2A. MacroH2A also represses RNA polymerase II transcription (Doyen et al. 2006). In agreement with this, macroH2A is depleted from active genes (Changolkar and Pehrson 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: X-chromosome inactivation (XCI) results in the transcriptional silencing of one X-chromosome in females to attain gene dosage parity between XX female and XY male mammals. Mammals appear to have developed rather diverse strategies to initiate XCI in early development. In placental mammals XCI depends on the regulatory noncoding RNA X-inactive specific transcript (Xist), which is absent in marsupials and monotremes. Surprisingly, even placental mammals show differences in the initiation of XCI in terms of Xist regulation and the timing to acquire dosage compensation. Despite this, all placental mammals achieve chromosome-wide gene silencing at some point in development, and this is maintained by epigenetic marks such as chromatin modifications and DNA methylation. In this review, we will summarise recent findings concerning the events that occur downstream of Xist RNA coating of the inactive X-chromosome (Xi) to ensure its heterochromatinization and the maintenance of the inactive state in the mouse and highlight similarities and differences between mammals.
    Human Genetics 06/2011; 130(2):307-27. DOI:10.1007/s00439-011-1029-2 · 4.82 Impact Factor
Show more